Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt New pharmaceutical legislation enters into force on 20 May 2004 3 maj 2004Press release European Medicines Agency Public Statement on the lifting of the suspension of the marketing authorisation for Tolcapone (Tasmar) 29 april 2004NewsMedicines European Agency for the Evaluation of Medicinal Products: Committee for Proprietary Medicinal Products, 20-24 April 2004 22 april 2004Press release EMEA releases recommendations for better information for patients 22 april 2004Press release Meeting of the EMEA working party on herbal medicinal products 1 - 2 April 2004 19 april 2004Press releaseHerbal Committee for medicinal products for veterinary use: Meeting of 14 to 15 April 2004 16 april 2004Press releaseVeterinary Committee for Orphan Medicinal Products: April 2004 meeting 16 april 2004Press releaseHumanRare diseases EMEA sets out its road map to 2010 15 april 2004Press release EMEA strengthens handling of safety concerns for human medicines 15 april 2004Press release EMEA launches action plan for improvements for human medicines 1 april 2004Press release 1 … 341 342 343 344 345 Page 345 of 380 346 347 348 349 … 380
European Medicines Agency Public Statement on the lifting of the suspension of the marketing authorisation for Tolcapone (Tasmar) 29 april 2004NewsMedicines
European Agency for the Evaluation of Medicinal Products: Committee for Proprietary Medicinal Products, 20-24 April 2004 22 april 2004Press release
Meeting of the EMEA working party on herbal medicinal products 1 - 2 April 2004 19 april 2004Press releaseHerbal
Committee for medicinal products for veterinary use: Meeting of 14 to 15 April 2004 16 april 2004Press releaseVeterinary
Committee for Orphan Medicinal Products: April 2004 meeting 16 april 2004Press releaseHumanRare diseases
